Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omaveloxolone in mitochondrial myopathy
NCT02255422Phase 2Completed
- Sponsor
- Biogen
- Start
- May 2015
- Primary completion
- Nov 2017
- Countries
- 2
01
Overview
A Phase 2 trial of omaveloxolone in mitochondrial myopathy (MM), sponsored by Biogen. Started May 2015; status: completed.
02
Drugs
omaveloxolone
03
Conditions
mitochondrial myopathy (MM)
Beyond the preview
Go deeper on NCT02255422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02255422.